Quick10K

⚲

Vegalab

Filings

10-Q	2018-06-30	Filed 2018-08-30
10-Q	2018-03-31	Filed 2018-07-13
10-K	2017-12-31	Filed 2018-06-04
10-Q	2017-09-30	Filed 2017-11-17
10-Q	2017-06-30	Filed 2017-08-21
10-Q	2017-03-31	Filed 2017-07-21
10-K	2016-12-31	Filed 2017-07-21
10-Q	2016-09-30	Filed 2016-11-21
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-13
10-K	2015-12-31	Filed 2016-03-29
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-12
10-Q	2015-03-31	Filed 2015-05-14
10-K	2014-12-31	Filed 2015-03-31
10-Q	2014-09-30	Filed 2014-11-12
10-Q	2014-06-30	Filed 2014-08-11
10-Q	2014-03-31	Filed 2014-05-14
10-K	2013-12-31	Filed 2014-03-31
10-Q	2013-09-30	Filed 2013-11-12
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-13
10-K	2012-12-31	Filed 2013-03-12
10-Q	2012-09-30	Filed 2012-11-08
10-Q	2012-06-30	Filed 2012-08-13
10-Q	2012-03-31	Filed 2012-05-08
10-K	2011-12-31	Filed 2012-03-15
10-Q	2011-09-30	Filed 2011-11-08
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-12
10-K	2010-12-31	Filed 2011-03-01
10-Q	2010-09-30	Filed 2010-10-28
10-Q	2010-06-30	Filed 2010-08-13
10-Q	2010-03-31	Filed 2010-05-14
10-K	2009-12-31	Filed 2010-03-17

Reports

8-K	2019-07-17
8-K	2019-01-31
8-K	2018-11-08
8-K	2018-09-07
8-K	2018-08-28
8-K	2018-08-14
8-K	2018-02-20
8-K	2017-12-29

Vegalab Financials

VEGL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Cell Medx (CMXC)	5,757		-6.5	-472%	191	1,963	0	0	-899	-882	5,700
Easterly Acquisition (EACQ)	68,264		22.5	2%	146,697	10,863	0	0	3,039	3,039	68,262
Poage Bankshares (PBSK)	68,196		17.6	-1%	440,728	379,510	0	0	-2,208	2,582	45,344
Omnicomm Systems (OMCM)	67,280	81%	-19.4	-44%	11,253	24,136	19,457	15,843	-4,922	-3,707	71,940
Prime Meridian Holding (PMHG)	66,178	0%	-3.7	1%	484,066	429,039	142	0	2,595	4,868	-18,100
Helix TCS (HLIX)	65,696	44%	-12.3	-12%	74,083	7,816	11,011	4,865	-8,865	-5,311	65,477
Yatra (TRTL)	65,640		-20.6	-3%	99,561	6,580	0	0	-3,178	-3,178	65,500
Vegalab (VEGL)	65,417	14%	-32.6	-22%	10,374	4,714	11,635	1,671	-2,270	-2,012	65,545
Integrity Applications (IGAP)	64,825	0%	-72.7	-44%	1,974	2,836	140	0	-874	-874	63,546
Radisys (RSYS)	64,574	27%	-97.1	-33%	57,835	65,385	109,918	29,205	-19,359	-578	56,127
Peoples Financial (PFBX)	64,261		11.4	0%	617,489	523,162	0	0	553	3,135	35,782
Electrum Special Acquisition (ELECU)	64,124		-356.8	-0%	128,485	11,837	0	0	-180	-180	64,096
Summer Energy (SUME)	63,005	9%	-19.8	-9%	60,900	51,472	130,021	11,888	-5,619	-3,470	68,685
Sonim Technologies (SONM)	62,906	32%	-3.4	-28%	68,973	40,342	99,081	31,437	-19,057	-16,692	56,855
Cryo Cell (CCEL)	62,661	68%	27.7	1%	40,889	48,983	23,494	15,913	575	2,439	67,644
I-On Communications (ALES)	62,354	20%	-80.0	-13%	8,863	2,470	5,283	1,043	-1,111	-758	60,670
Nephros (NEPH)	62,276	58%	-14.8	-38%	11,554	4,832	8,942	5,182	-4,384	-4,006	59,300
Kaanapali Land (KANP)	62,158	7%	-9.8	-3%	106,294	24,515	4,885	364	-2,988	-3,678	36,038
Imprimis Pharmaceuticals (IMMY)	62,078	77%	-27.3	-14%	28,289	23,836	29,988	23,163	-4,097	-2,510	68,431
INmune Bio (INMB)	61,884		-10.2	-21%	25,396	687	0	0	-5,360	-5,360	54,502


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Cash	0	0	0	0	0	0	0	0	1	0	5	0	1	34	2	0	0	78	90	46	225	0	39	126	130	343	647	222
Accounts Receivable														2	2	0	0	0		746	170	671	732	737	715	1,675	1,834	964
Inventory																			704	688	2,332	1,889	1,965	1,902	1,472	1,595	1,528	3,659
PP&E																								19	23	1,021	1,104	1,239
Assets	4	2	1	0	3	2	0	0	2	2	6	0	6	36	11	5	3	80	807	1,485	2,744	2,596	2,777	2,821	2,368	4,787	9,544	10,374
Accounts Payable	2	2			2	2	3	3	3	3	12	12	22	22	15	15	19	3	33	2	6	68	105	63	111	409	988	1,628
Long-Term Debt																										429	350	350
Liabilities	52	54	59	62	67	70	74	77	84	89	121	122	157	250	246	250	257	244	437	803	2,098	1,990	2,166	2,049	1,626	2,438	2,893	4,714
Stockholders' Equity	-44	-52	-58	-62	-65	-68	-74	-77	-82	-87	-115	-122	151	-214	-235	-245	-254	-165	369	683	645	606	611	772	742	2,349	6,651	5,660


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Revenue	0		0	0	0	0	0	0	0	0	0				0	0	0	0	0	1,433	155	528	209	167	180		7,289	4,166
Cost of Revenue																				1,052	104	461	189	121	167		5,696	4,457
Gross Profit																				381	50	67	19	46	13	356	1,593	-290
R&D																				8
SG&A	2	2	2	2	0	1	2	2	2	2	3	2	5	9	1	4	3	2	5	45	75	492	259	495	223	1,156	1,642	717
Tax	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	65	0	-48	0	0	0	0	0	0
Net Income	-4	-4	-5	-5	-2	-4	-6	-3	-5	-4	-29	-7	102	-193	-22	-9	-9	-11	-49	193	-37	-224	-225	-254	-210	-985	-57	-1,018


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Cash Operating		-2	-2	-4	-4	-2	-2	-2	-5	-5	-16	-5	65	-145	-32	-3	-2	-22	-362	-163	4	-225	-160	-175		-949	501	-284
Cash Investing		0	0	0	0	0	0			0	0				0	0	0	0	0	0						-550	-196	-138
Cash Financing		2	2	4	4	2	2	2	5	4	22	0	23	91	0	1	2	100	373	120	175	0	199	273		1,711	-1	-2